✦ LIBER ✦

Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients

✍ Scribed by John S. Moody; Stephen M. Sawrie; Kevin R. Kozak; John P. Plastaras; George Howard; James A. Bonner

Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 349 KB
Volume: 44
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-008-2280-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival benefits of adjuvant chemothera

Survival benefits of adjuvant chemotherapy with oral doxifluridine (5′-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

✍ Koji Tsuruta; Astutake Okamoto; Naoto Egawa; Terumi Kamisawa; Katsuyuki Karasawa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## Background and Objectives The combination of 5‐fluorouracil and radiotherapy is thought to be the most effective treatment for locally unresectable pancreatic carcinoma. The outcomes, however, are far from acceptable from the viewpoint of long‐term survival. We assessed the survival

Expression of p21WAF1in Astler–Coller st

Expression of p21WAF1in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy

✍ Violetta Sulzyc-Bielicka; Pawel Domagala; Elzbieta Urasinska; Dariusz Bielicki; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 575 KB

In several, but not all, previous studies, positive p21^WAF1^ expression has been suggested as an indicator of a good prognosis in patients with stage III/IV colorectal cancer. However, it is not known whether the same is true for stage B2 patients. The purpose of this study is to assess the influen

Association between receipt and timing o

Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada

✍ Isac S. F. Lima; Yutaka Yasui; Andrew Scarfe; Marcy Winget 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m